Definium Therapeutics, Inc. DFTX
Set alert
32.47 USD -3.86 -10.62%
At close · Nov 2
32.53 +0.06 +0.18%
After hours · Nov 2, 5:09 PM ET
31.61 Day range 36.84
10.47 52-week range 49.70
- YTD
- +142.49%
- 1 year
- +128.66%
- Open
- 36.51
- Prev close
- 36.33
- Mkt cap
- 4.36B
- Vol
- 3.65M
- Avg vol
- 2.15M
- EPS
- -3.43
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 31.61
- High
- 36.84
- Forward P/E
- -16.73
- Beta
- 2.21
- Short ratio
- 4.32
- Inst. own
- 96.39%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 37.77
- 200-d avg
- 29.60
- 1y target
- 72.56
3M chart
Events in this range
- Aug 6, 2026Earnings: -1.44; estimate -0.54102; surprise -166.16%
- Sep 11, 2026Rating: RBC Capital · Outperform → Outperform
- Sep 14, 2026Rating: Needham · Buy → Buy
- Sep 14, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Sep 15, 2026Rating: Baird · Outperform → Outperform
- Sep 15, 2026Rating: Canaccord Genuity · Buy → Buy
- Oct 9, 2026Rating: JP Morgan · — → Overweight
Signals (17)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 12 hours ago |
| SMA: Bearish | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
Financial health
Altman Z-Score
12.28 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -6.5×
FY 2016 5y median -4.5× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.6×
FY 2016 5y median 2.0× FY 2025
P/FCF -9.1×
FY 2016 5y median -6.2× FY 2025
EV/EBITDA -5.3×
FY 2016 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -11.0%
FY 2016 5y median -16.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -55.3%
FY 2016 5y median -55.3% FY 2025
ROIC -44.5%
FY 2016 5y median -44.5% FY 2025
ROA -41.8%
FY 2016 5y median -41.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -60.0%
FY 2016 FY 2025
EPS (diluted) -1273.3%
FY 2016 FY 2025
Free Cash Flow -66.3%
FY 2016 FY 2025
Financial Health
Current Ratio 6.3×
FY 2016 5y median 7.2× FY 2025
Quick Ratio 6.3×
FY 2016 5y median 7.2× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.4×
FY 2016 5y median 1.5× FY 2025
Interest Coverage -30.3×
FY 2016 5y median -45.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31